{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:14:57Z","timestamp":1780492497104,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.vaccine.2022.06.026","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T01:55:06Z","timestamp":1655085306000},"page":"4522-4530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["RelCoVax\u00ae, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice"],"prefix":"10.1016","volume":"40","author":[{"given":"Abhishek","family":"Phatarphekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.E.C.","family":"Vidyadhar Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhiram","family":"Gokhale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopala","family":"Karanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pushpa","family":"Kuchroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketaki","family":"Shinde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Masand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Pagare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh","family":"Khadpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangita S.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijita","family":"Vijayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L.","family":"Ramnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Pratap Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Harinarayana Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkata","family":"Ramana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.vaccine.2022.06.026_b0005","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra032498","article-title":"The Severe Acute Respiratory Syndrome","volume":"349","author":"Peiris","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2022.06.026_b0010","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1128\/JVI.01244-13","article-title":"Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group","volume":"87","author":"de Groot","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2022.06.026_b0015","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2022.06.026_b0020","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","article-title":"An interactive web-based dashboard to track COVID-19 in real time","volume":"20","author":"Dong","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2022.06.026_b0025","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1126\/science.abc5312","article-title":"A strategic approach to COVID-19 vaccine R&D","volume":"368","author":"Corey","year":"2020","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.026_b0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"npj Vaccines"},{"issue":"7807","key":"10.1016\/j.vaccine.2022.06.026_b0035","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"issue":"21","key":"10.1016\/j.vaccine.2022.06.026_b0040","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"550","key":"10.1016\/j.vaccine.2022.06.026_b0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc3539","article-title":"Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits","volume":"12","author":"Ravichandran","year":"2020","journal-title":"Sci Transl Med"},{"issue":"48","key":"10.1016\/j.vaccine.2022.06.026_b0050","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abc8413","article-title":"The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients","volume":"5","author":"Premkumar","year":"2020","journal-title":"Sci Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2022.06.026_b0055","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"issue":"7883","key":"10.1016\/j.vaccine.2022.06.026_b0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"issue":"7871","key":"10.1016\/j.vaccine.2022.06.026_b0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41586-021-03777-9","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","volume":"596","author":"Planas","year":"2021","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.vaccine.2022.06.026_b0070","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00647-20","article-title":"The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development","volume":"94","author":"Dutta","year":"2020","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2022.06.026_b0075","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.apsb.2020.04.009","article-title":"Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites","volume":"10","author":"Kang","year":"2020","journal-title":"Acta Pharm Sin B"},{"issue":"7821","key":"10.1016\/j.vaccine.2022.06.026_b0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-020-2550-z","article-title":"SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls","volume":"584","author":"Le Bert","year":"2020","journal-title":"Nature"},{"issue":"1-2","key":"10.1016\/j.vaccine.2022.06.026_b0085","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijpharm.2016.12.019","article-title":"NaCl strongly modifies the physicochemical properties of aluminum hydroxide vaccine adjuvants","volume":"517","author":"Art","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2022.06.026_b0090","series-title":"Vaccine Adjuvants, Methods in Molecular Medicine","first-page":"65","article-title":"Aluminum Compounds as Vaccine Adjuvants","author":"Gupta","year":"2000"},{"key":"10.1016\/j.vaccine.2022.06.026_b0095","series-title":"Vaccine Adjuvants, Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/978-1-4939-6445-1_2","article-title":"Development of the CpG Adjuvant 1018: A Case Study","author":"Campbell","year":"2017"},{"issue":"7798","key":"10.1016\/j.vaccine.2022.06.026_b0100","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"issue":"7807","key":"10.1016\/j.vaccine.2022.06.026_b0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","article-title":"Structural basis of receptor recognition by SARS-CoV-2","volume":"581","author":"Shang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2022.06.026_b0110","doi-asserted-by":"crossref","unstructured":"MI, MacGowan SA, Kutuzov MA, Dushek O, Barton GJ, Van der Merwe PA. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics. Elife 2021;10:e70658. https:\/\/doi.org\/10.7554\/eLife.70658.","DOI":"10.7554\/eLife.70658"},{"issue":"3","key":"10.1016\/j.vaccine.2022.06.026_b0115","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4161\/hv.27464","article-title":"Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate","volume":"10","author":"Chen","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.026_b0120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77077-z","article-title":"Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19","volume":"10","author":"Kuo","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2022.06.026_b0125","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-21634-1","article-title":"S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates","volume":"12","author":"Liang","year":"2021","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.vaccine.2022.06.026_b0130","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41576-021-00408-x","article-title":"The biological and clinical significance of emerging SARS-CoV-2 variants","volume":"22","author":"Tao","year":"2021","journal-title":"Nat Rev Genet"},{"issue":"18","key":"10.1016\/j.vaccine.2022.06.026_b0135","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01279-20","article-title":"The SARS-CoV-2 N Protein Is a Good Component in a Vaccine","volume":"94","author":"Ahl\u00e9n","year":"2020","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2022.06.026_b0140","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4049\/jimmunol.2100421","article-title":"Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity","volume":"207","author":"Matchett","year":"2021","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2022.06.026_b0145","doi-asserted-by":"crossref","first-page":"109664","DOI":"10.1016\/j.celrep.2021.109664","article-title":"Combining spike- and nucleocapsid-based vaccines improves distal control of SARS-CoV-2","volume":"36","author":"Dangi","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.vaccine.2022.06.026_b0150","doi-asserted-by":"crossref","unstructured":"Dangi T, Palacio N, Sanchez S, et al. Cross-protective immunity following coronavirus vaccination and coronavirus infection. J Clin Invest 2021;131: e151969. https:\/\/doi.org\/10.1172\/JCI151969.","DOI":"10.1172\/JCI151969"},{"issue":"5","key":"10.1016\/j.vaccine.2022.06.026_b0155","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106228","article-title":"Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity","volume":"40","author":"Caddy","year":"2021","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2022.06.026_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.729837","article-title":"Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge","volume":"12","author":"Gabitzsch","year":"2021","journal-title":"Front Immunol"},{"issue":"22","key":"10.1016\/j.vaccine.2022.06.026_b0165","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abg7156","article-title":"Immunization with RBD-P2 and N protects against SARS-CoV-2 in nonhuman primates","volume":"7","author":"Hong","year":"2021","journal-title":"Sci Adv"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X22007757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:16:13Z","timestamp":1759403773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X22007757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":33,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0264410X22007757"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.026","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.01.07.475330","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RelCoVax\u00ae, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2022.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}